U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07125924) titled 'Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer' on Aug. 03.
Brief Summary: To evaluate the efficacy and safety of intravesical hyaluronic acid (HA) instillation therapy for the prevention of radiation-induced cystitis in patients undergoing radiotherapy for bladder cancer.
Study Start Date: Aug. 22
Study Type: INTERVENTIONAL
Condition:
Bladder Cancer
Radiation Cystitis
Intervention:
DEVICE: Blad-Care (sodium hyaluronate 1.6%, 800 mg/50 mL, BioPlus Co., Ltd.)
Bladder instillation of Blad-Care (sodium hyaluronate 1.6%, 800 mg/50 mL, BioPlus Co., Ltd.) will be administered aseptically once ...